Brumath, France

Dominique Burnouf



 

Average Co-Inventor Count = 3.7

ph-index = 1


Company Filing History:


Years Active: 2015-2024

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Dominique Burnouf

Introduction

Dominique Burnouf is a notable inventor based in Brumath, France. He has made significant contributions to the field of antimicrobial agents through his innovative research and development. With a total of 2 patents, Burnouf's work focuses on the creation of fusion peptides and compounds that enhance the understanding of bacterial replication.

Latest Patents

Burnouf's latest patents include "Fusion peptides as antimicrobial agents" and "Compounds binding to the bacterial beta ring." The first patent describes a fusion peptide characterized by specific formulae, which includes proline-rich antimicrobial peptides and a peptide linker. This invention aims to provide new antimicrobial agents that can effectively combat bacterial infections. The second patent relates to compounds that bind to the hydrophobic pocket of the beta clamp, enhancing their affinity to target proteins involved in bacterial DNA replication.

Career Highlights

Throughout his career, Dominique Burnouf has worked with prestigious institutions such as the Centre National de la Recherche Scientifique and the University of Strasbourg. His research has contributed to advancements in the understanding of antimicrobial peptides and their applications in medicine.

Collaborations

Burnouf has collaborated with notable colleagues, including Gilles Guichard and Jérôme Wagner. These partnerships have fostered a collaborative environment that promotes innovation and the sharing of ideas in the scientific community.

Conclusion

Dominique Burnouf's contributions to the field of antimicrobial research highlight his innovative spirit and dedication to advancing science. His patents reflect a commitment to developing effective solutions for combating bacterial infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…